Ureteral Stent Exchange Abstention in Urinary Tract Infections
- Conditions
- Urinary Tract InfectionsUrinary Catheterization
- Registration Number
- NCT06503588
- Lead Sponsor
- Central Hospital, Nancy, France
- Brief Summary
The Committee of Infectiology of the French Association of Urology (CIAFU) provided, for the first time in 2020, comprehensive guidelines for ureteral stent-associated urinary tract infections (USAUTI) prevention, diagnosis and treatment. Since evidence lacked in terms of appropriate treatment, guidelines could not support systematic change of US in case of USAUTI.
This study aims to evaluate whether "after guidelines group" patients treated for USAUTI had different occurrence of at least one relapse or recurrence than "before guidelines group".
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 300
- All patients with indwelling ureteral catheter
- AND confirmed or probable urinary tract infection
- Patient's opposition
- History of ileal conduit urinary diversion
- Second or more urinary tract infection during the study period
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Relapse OR recurrence of urinary tract infection 1 year
- Secondary Outcome Measures
Name Time Method Nephro-urologic complication 1 year Acute kidney injury ; hematuria ; pain ; stent migration or incrustation
Infectious complication 1 year Sepsis or septic shock
In-hospital and 1-year mortality 1 year all cause death
Resort to Watch or Reserve antibiotics 1 year antibiotics' WHO classifcation
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Nancy university hospital
🇫🇷Nancy, Lorraine, France
Nancy university hospital🇫🇷Nancy, Lorraine, FranceBenjamin Lefevre, MD PhDContact+33383154097b.lefevre@chru-nancy.fr